Spotted fever rickettsiosis is the group of acute febrile illnesses caused by the spotted fever group (SFG) of the genus Rickettsia — obligately intracytosolic, Gram-negative bacteria acquired from a feeding tick (or, for rickettsialpox, a mite). Whatever the species, the mechanism is the same: the organism is inoculated at the arthropod attachment site, disseminates haematogenously, and replicates inside microvascular endothelial cells, producing a disseminated small-vessel vasculitis with increased vascular permeability. That single lesion accounts for the group's shared clinical signature — fever, headache and myalgia, a centrifugally or centripetally spreading rash, and (in most members, though notably not in Rocky Mountain spotted fever) an inoculation eschar at the bite site — and, at the severe end, for non-cardiogenic pulmonary oedema and encephalitis. Members differ enormously in severity, from the self-limiting African tick-bite fever to the frequently fatal Rocky Mountain spotted fever, and that gradient tracks the species-specific inflammatory response the organism provokes in endothelium rather than any difference in the route of infection. This root entry is deliberately thin. It carries only what is defined over the group as a whole: the SFG taxon itself and the species-versus-geography naming problem, the shared eschar/fever/rash triad and how eschar frequency varies by species, the group-level serologic cross-reactivity that makes species-level diagnosis hard, the shared doxycycline-first-line logic including its paediatric arm, and the SFG-versus-typhus-group boundary. Per-member pathophysiology, epidemiology, phenotype frequencies and treatment detail live in the individual entries — `Rocky_Mountain_Spotted_Fever.yaml` and `Boutonneuse_Fever.yaml` are curated in full — and the antimicrobial mechanism is held once in `kb/modules/bacterial_protein_synthesis_inhibition.yaml` and `kb/modules/intracellular_pathogen_persistence.yaml`.
Ask a research question about Spotted fever rickettsiosis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Spotted fever rickettsiosis
creation_date: '2026-08-19T00:00:00Z'
category: Infectious Disease
description: >
Spotted fever rickettsiosis is the group of acute febrile illnesses caused by the
spotted fever group (SFG) of the genus Rickettsia — obligately intracytosolic,
Gram-negative bacteria acquired from a feeding tick (or, for rickettsialpox, a
mite). Whatever the species, the mechanism is the same: the organism is inoculated
at the arthropod attachment site, disseminates haematogenously, and replicates
inside microvascular endothelial cells, producing a disseminated small-vessel
vasculitis with increased vascular permeability. That single lesion accounts for
the group's shared clinical signature — fever, headache and myalgia, a
centrifugally or centripetally spreading rash, and (in most members, though
notably not in Rocky Mountain spotted fever) an inoculation eschar at the bite
site — and, at the severe end, for non-cardiogenic pulmonary oedema and
encephalitis. Members differ enormously in severity, from the self-limiting
African tick-bite fever to the frequently fatal Rocky Mountain spotted fever, and
that gradient tracks the species-specific inflammatory response the organism
provokes in endothelium rather than any difference in the route of infection.
This root entry is deliberately thin. It carries only what is defined over the
group as a whole: the SFG taxon itself and the species-versus-geography naming
problem, the shared eschar/fever/rash triad and how eschar frequency varies by
species, the group-level serologic cross-reactivity that makes species-level
diagnosis hard, the shared doxycycline-first-line logic including its paediatric
arm, and the SFG-versus-typhus-group boundary. Per-member pathophysiology,
epidemiology, phenotype frequencies and treatment detail live in the individual
entries — `Rocky_Mountain_Spotted_Fever.yaml` and `Boutonneuse_Fever.yaml` are
curated in full — and the antimicrobial mechanism is held once in
`kb/modules/bacterial_protein_synthesis_inhibition.yaml` and
`kb/modules/intracellular_pathogen_persistence.yaml`.
disease_term:
preferred_term: spotted fever
term:
id: MONDO:0001195
label: spotted fever
synonyms:
- Spotted fever
- Spotted fever group rickettsiosis
- SFG rickettsioses
- Spotted fever rickettsiae disease
- Tick-borne rickettsiosis
parents:
- Rickettsiaceae infectious disease
- Vector-borne disease
- Rickettsial disease
classifications:
harrisons_chapter:
- classification_value: INFECTIOUS_DISEASES
evidence:
- reference: PMID:24092850
reference_title: "Update on tick-borne rickettsioses around the world: a geographic approach."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Tick-borne rickettsioses are caused by obligate intracellular bacteria
belonging to the spotted fever group of the genus Rickettsia.
explanation: >-
The spotted fever group rickettsioses are acute bacterial infections acquired
from an arthropod vector, placing the group in Harrison's Infectious Diseases
Part. Evidence source is OTHER as this is a review article.
has_subtypes:
- name: RMSF
display_name: Rocky Mountain spotted fever (Rickettsia rickettsii)
classification: etiologic_species
geography:
- United States
- Mexico
- Central America
- Brazil
- Argentina
description: >-
Caused by Rickettsia rickettsii and transmitted by Dermacentor and Rhipicephalus
ticks. The most severe member of the group and the one in which an inoculation
eschar is characteristically absent. Its range demonstrates that the species axis
and the geographic axis do not coincide: the same organism causes Rocky Mountain
spotted fever in North America and Brazilian spotted fever / febre maculosa in
South America. Curated in full in `Rocky_Mountain_Spotted_Fever.yaml`.
subtype_term:
preferred_term: Rocky mountain spotted fever
term:
id: MONDO:0019359
label: Rocky mountain spotted fever
evidence:
- reference: PMID:17961858
reference_title: Rocky Mountain spotted fever.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Rocky Mountain spotted fever (RMSF) is a life-threatening disease caused by
Rickettsia rickettsii, an obligately intracellular bacterium that is spread to
human beings by ticks.
explanation: >-
Names the causative species and the tick route for this member. Evidence source
is OTHER as this is a review article.
- reference: PMID:28169507
reference_title: Predictive Factors for Fatal Tick-Borne Spotted Fever in Brazil.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In Brazil, two pathogenic Rickettsia species have been identified causing
tick-borne spotted fever (SF).
explanation: >-
Establishes that R. rickettsii spotted fever is a South American as well as a
North American disease — the concrete case in which the species and geographic
axes come apart.
- name: MSF
display_name: Mediterranean spotted fever / boutonneuse fever (Rickettsia conorii)
classification: etiologic_species
geography:
- Mediterranean basin
- Southern Europe
- North Africa
- Sub-Saharan Africa
- Middle East
- India
description: >-
Caused by Rickettsia conorii and transmitted by the brown dog tick Rhipicephalus
sanguineus; the inoculation eschar is the classic tache noire. This member is the
clearest illustration of why the primary axis is the species and not the place:
one species carries four geographically named diseases — Mediterranean spotted
fever (subsp. conorii), Indian tick typhus (subsp. indica), Israeli spotted fever
(subsp. israelensis) and Astrakhan fever (subsp. caspia). Curated in full in
`Boutonneuse_Fever.yaml`.
subtype_term:
preferred_term: boutonneuse fever
term:
id: MONDO:0024472
label: boutonneuse fever
evidence:
- reference: PMID:23168048
reference_title: Mediterranean spotted fever in the Trakya region of Turkey.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Mediterranean spotted fever (MSF) is caused by a tick-borne pathogen, Rickettsia
conorii subsp. conorii, belonging to the spotted fever group (SFG) rickettsiae.
explanation: >-
Names the causative subspecies and states its membership of the spotted fever
group.
- reference: PMID:15766388
reference_title: >-
Proposal to create subspecies of Rickettsia conorii based on multi-locus sequence
typing and an emended description of Rickettsia conorii.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Rickettsiae closely related to the Malish strain, the reference Rickettsia conorii
strain, include Indian tick typhus rickettsia (ITTR), Israeli spotted fever
rickettsia (ISFR), and Astrakhan fever rickettsia (AFR).
explanation: >-
Enumerates the four geographically named diseases that a single species accounts
for, which is the evidence behind treating species as the primary subtype axis.
- name: ATBF
display_name: African tick-bite fever (Rickettsia africae)
classification: etiologic_species
geography:
- Sub-Saharan Africa
- Eastern Caribbean
description: >-
Caused by Rickettsia africae and transmitted by Amblyomma ticks. The mildest
commonly encountered member: a self-limiting flu-like illness in which fever,
headache and myalgia are near-universal but the specific features — inoculation
eschars (often multiple), lymphadenitis and rash — are present in only about half
of patients. The commonest tick-borne rickettsiosis in returning travellers. No
standalone dismech entry yet.
subtype_term:
preferred_term: African tick-bite fever
term:
id: MONDO:0000227
label: African tick-bite fever
evidence:
- reference: PMID:12766836
reference_title: African tick bite fever in travelers to rural sub-Equatorial Africa.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
More than 80% of the patients had fever, headache, and/or myalgia, whereas
specific clinical features such as inoculation eschars, lymphadenitis, cutaneous
rash, and aphthous stomatitis were seen in < or = 50% of patients.
explanation: >-
A prospective cohort of 940 travellers quantifying the ATBF presentation, and
showing that the eschar is not a constant feature even in a member of the group
in which it is characteristic.
- reference: PMID:19091423
reference_title: >-
Relative chemokine and adhesion molecule expression in Mediterranean spotted
fever and African tick bite fever.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Mediterranean spotted fever (MSF) caused by Rickettsia conorii (R. conorii) is a
potential lethal disease while African tick bite fever (ATBF) caused by
Rickettsia africae is a self-limiting flu-like illness.
explanation: >-
States the severity contrast between two members of the same group, which is what
makes species rather than geography the discriminating axis.
- name: Rickettsialpox
display_name: Rickettsialpox (Rickettsia akari)
classification: etiologic_species
geography:
- United States
- Ukraine
- Croatia
- Turkey
- Republic of Korea
description: >-
Caused by Rickettsia akari, and the one member of this list that is not
tick-borne: it is transmitted by the house mouse mite Liponyssoides sanguineus in
an urban rodent cycle. An eschar at the mite bite is followed by a papulovesicular
rash. Its inclusion is deliberate and is what fixes the group's unifying criterion
as the rickettsial clade rather than the arthropod vector; see the
`sfr_group_boundary_and_naming_traps` discussion, which also records that R. akari
has since been reassigned to the transitional group. No standalone dismech entry
yet.
subtype_term:
preferred_term: rickettsialpox
term:
id: MONDO:0019360
label: rickettsialpox
evidence:
- reference: PMID:12860597
reference_title: "Rickettsialpox in New York City: a persistent urban zoonosis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
IHC staining of biopsy specimens of eschars and papular lesions were positive for
spotted fever group rickettsiae for 32 patients.
explanation: >-
Confirmed rickettsialpox cases staining positive for spotted fever group
rickettsiae — the serologic and immunohistochemical basis on which the disease is
classified with this group.
- reference: PMID:28846279
reference_title: Rickettsia akari (Rickettsialpox).
supports: SUPPORT
evidence_source: OTHER
snippet: >-
R. akari is transmitted by the house mouse mite, Liponyssoides sanguineus.
explanation: >-
States the mite (not tick) vector, the fact that prevents the group from being
defined by its arthropod. Evidence source is OTHER as this is a reference-text
chapter rather than a primary study.
- name: QTT
display_name: Queensland tick typhus (Rickettsia australis)
classification: etiologic_species
geography:
- Eastern Australia
description: >-
Caused by Rickettsia australis and transmitted by Ixodes holocyclus and Ixodes
tasmani. Despite the word "typhus" in its name this is a spotted fever group
infection, not a typhus group one — see the `sfr_group_boundary_and_naming_traps`
discussion. No standalone dismech entry yet.
subtype_term:
preferred_term: Queensland tick typhus
term:
id: MONDO:0001118
label: Queensland tick typhus
evidence:
- reference: PMID:28719297
reference_title: >-
Rickettsia australis and Queensland Tick Typhus: A Rickettsial Spotted Fever
Group Infection in Australia.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Rickettsia australis, the etiologic agent of Queensland tick typhus (QTT), is
increasingly being recognized as a cause of community-acquired acute febrile
illness in eastern Australia.
explanation: >-
Names the causative species and the geographic range, and — in a review whose
title states the point explicitly — places a disease called "tick typhus" in the
spotted fever group. Evidence source is OTHER as this is a review article.
- name: NATT
display_name: North Asian (Siberian) tick typhus (Rickettsia sibirica subsp. sibirica)
classification: etiologic_species
geography:
- Siberia
- Eastern China
- Mongolia
- Kazakhstan
description: >-
Caused by Rickettsia sibirica subsp. sibirica and transmitted by Dermacentor and
Haemaphysalis ticks. The second "tick typhus" in this list that is in fact a
spotted fever group disease. Note that the sibling subspecies R. sibirica subsp.
mongolitimonae causes a separate Mediterranean-spotted-fever-like illness in Europe
and Africa, so even within one species the geographic label is not a reliable
identifier. No standalone dismech entry yet.
subtype_term:
preferred_term: Siberian tick typhus
term:
id: MONDO:0001154
label: Siberian tick typhus
evidence:
- reference: PMID:22493192
reference_title: Sequence and annotation of Rickettsia sibirica sibirica genome.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Rickettsia sibirica sibirica is the causative agent of Siberian or North Asian
tick typhus, a tick-borne rickettsiosis known to exist in Siberia and eastern
China.
explanation: >-
Establishes the subspecies-to-disease mapping and the geographic range, and
confirms that the entity called North Asian tick typhus is a rickettsiosis of
this group. Evidence source is OTHER as this is a genome announcement.
infectious_agent:
- name: Spotted fever group Rickettsia
infectious_agent_term:
preferred_term: spotted fever group
term:
id: NCBITaxon:114277
label: spotted fever group
description: >-
The taxon that defines this disease group. SFG rickettsiae are obligately
intracytosolic Gram-negative bacteria that cycle between an arthropod vector and a
vertebrate host and that share an endothelial tropism in humans. Membership of this
clade — not the identity of the arthropod, and not the geography of the disease
name — is the unifying criterion for the entries grouped here.
evidence:
- reference: PMID:24092850
reference_title: "Update on tick-borne rickettsioses around the world: a geographic approach."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Tick-borne rickettsioses are caused by obligate intracellular bacteria belonging
to the spotted fever group of the genus Rickettsia.
explanation: >-
Defines the group by its taxon and by the obligate intracellular lifestyle.
Evidence source is OTHER as this is a review article.
- reference: PMID:24092850
reference_title: "Update on tick-borne rickettsioses around the world: a geographic approach."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Several species of tick-borne rickettsiae that were considered nonpathogenic for
decades are now associated with human infections, and novel Rickettsia species of
undetermined pathogenicity continue to be detected in or isolated from ticks
around the world.
explanation: >-
Establishes that the membership of this group is open and still growing, which is
why the subtype list below is explicitly non-exhaustive.
- name: Rickettsia rickettsii
infectious_agent_term:
preferred_term: Rickettsia rickettsii
term:
id: NCBITaxon:783
label: Rickettsia rickettsii
description: >-
Agent of Rocky Mountain spotted fever in North America and of Brazilian spotted
fever in South America; the most virulent member of the group.
evidence:
- reference: PMID:17961858
reference_title: Rocky Mountain spotted fever.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Rocky Mountain spotted fever (RMSF) is a life-threatening disease caused by
Rickettsia rickettsii, an obligately intracellular bacterium that is spread to
human beings by ticks.
explanation: >-
Assigns the species to its disease. Evidence source is OTHER as this is a review
article.
- name: Rickettsia conorii
infectious_agent_term:
preferred_term: Rickettsia conorii
term:
id: NCBITaxon:781
label: Rickettsia conorii
description: >-
Agent of Mediterranean spotted fever (boutonneuse fever) and, through its
subspecies indica, israelensis and caspia, of Indian tick typhus, Israeli spotted
fever and Astrakhan fever.
evidence:
- reference: PMID:15766388
reference_title: >-
Proposal to create subspecies of Rickettsia conorii based on multi-locus sequence
typing and an emended description of Rickettsia conorii.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Although homogeneous genotypically, strains within the R. conorii species show
MST genotypic, serotypic, and epidemio-clinical dissimilarities.
explanation: >-
Establishes that one genotypically homogeneous species underlies several
epidemiologically and clinically distinct named diseases. Evidence source is
OTHER as this is a bacterial taxonomy proposal.
- name: Rickettsia africae
infectious_agent_term:
preferred_term: Rickettsia africae
term:
id: NCBITaxon:35788
label: Rickettsia africae
description: >-
Agent of African tick-bite fever; a mild, self-limiting member of the group that
provokes a markedly weaker endothelial inflammatory response than R. conorii.
evidence:
- reference: PMID:19091423
reference_title: >-
Relative chemokine and adhesion molecule expression in Mediterranean spotted
fever and African tick bite fever.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Mediterranean spotted fever (MSF) caused by Rickettsia conorii (R. conorii) is a
potential lethal disease while African tick bite fever (ATBF) caused by
Rickettsia africae is a self-limiting flu-like illness.
explanation: Assigns the species to its disease and states its comparative severity.
- name: Rickettsia akari
infectious_agent_term:
preferred_term: Rickettsia akari
term:
id: NCBITaxon:786
label: Rickettsia akari
description: >-
Agent of rickettsialpox, transmitted by the house mouse mite rather than a tick.
Historically classified within the spotted fever group and still grouped with it
clinically and serologically, but reassigned to the transitional group on genomic
grounds.
evidence:
- reference: PMID:28846279
reference_title: Rickettsia akari (Rickettsialpox).
supports: SUPPORT
evidence_source: OTHER
snippet: >-
R. akari was initially classified as a member of the spotted fever group (SFG) of
rickettsia, but it is now placed in the transitional group, which has features of
both the spotted fever group and the typhus group (TG) of rickettsiae.
explanation: >-
States both the historical SFG placement that underlies the disease grouping and
the later genomic reassignment. Evidence source is OTHER as this is a
reference-text chapter.
- name: Rickettsia australis
infectious_agent_term:
preferred_term: Rickettsia australis
term:
id: NCBITaxon:787
label: Rickettsia australis
description: >-
Agent of Queensland tick typhus in eastern Australia. Like R. akari it has been
assigned to the transitional group on genomic grounds while remaining a spotted
fever group infection clinically.
evidence:
- reference: PMID:28719297
reference_title: >-
Rickettsia australis and Queensland Tick Typhus: A Rickettsial Spotted Fever
Group Infection in Australia.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Rickettsia australis, the etiologic agent of Queensland tick typhus (QTT), is
increasingly being recognized as a cause of community-acquired acute febrile
illness in eastern Australia.
explanation: >-
Assigns the species to its disease. Evidence source is OTHER as this is a review
article.
- name: Rickettsia sibirica subsp. sibirica
infectious_agent_term:
preferred_term: Rickettsia sibirica subsp. sibirica
term:
id: NCBITaxon:1144281
label: Rickettsia sibirica subsp. sibirica
description: >-
Agent of North Asian (Siberian) tick typhus across Siberia, Mongolia, Kazakhstan
and eastern China.
evidence:
- reference: PMID:22493192
reference_title: Sequence and annotation of Rickettsia sibirica sibirica genome.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Rickettsia sibirica sibirica is the causative agent of Siberian or North Asian
tick typhus, a tick-borne rickettsiosis known to exist in Siberia and eastern
China.
explanation: >-
Assigns the subspecies to its disease. Evidence source is OTHER as this is a
genome announcement.
transmission:
- name: Tick bite inoculation
description: >-
For every member of the group except rickettsialpox, the organism is inoculated by
a feeding ixodid tick. Which tick genus is involved varies by rickettsial species
and therefore by geography — Dermacentor and Rhipicephalus for R. rickettsii,
Rhipicephalus sanguineus for R. conorii, Amblyomma for R. africae, Ixodes for R.
australis — but the route is common to the group, and most patients cannot recall
the bite.
evidence:
- reference: PMID:24092850
reference_title: "Update on tick-borne rickettsioses around the world: a geographic approach."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Tick-borne rickettsioses are caused by obligate intracellular bacteria belonging
to the spotted fever group of the genus Rickettsia.
explanation: >-
Establishes the tick route as definitional for the group. Evidence source is
OTHER as this is a review article.
- reference: PMID:15109588
reference_title: Tick-borne rickettsioses in international travellers.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Only a minority of infected travellers can recall a preceding tick bite.
explanation: >-
A group-level observation with direct diagnostic consequence: an absent bite
history does not argue against the diagnosis. Evidence source is OTHER as this is
a literature-based review.
- name: Mite bite inoculation (rickettsialpox)
description: >-
Rickettsialpox is the exception to the tick route: R. akari is transmitted by the
house mouse mite Liponyssoides sanguineus in an urban rodent cycle. This is the
reason the group cannot be defined by its arthropod vector.
evidence:
- reference: PMID:28846279
reference_title: Rickettsia akari (Rickettsialpox).
supports: SUPPORT
evidence_source: OTHER
snippet: >-
R. akari is transmitted by the house mouse mite, Liponyssoides sanguineus.
explanation: >-
Names the mite vector for the one non-tick-borne member listed here. Evidence
source is OTHER as this is a reference-text chapter.
pathophysiology:
- name: Arthropod Inoculation of a Spotted Fever Group Rickettsia
biological_scale: ORGANISM
role: trigger
description: >-
A feeding tick — or, for rickettsialpox, a mite — deposits SFG rickettsiae in the
dermis at the attachment site. In most members of the group this produces a local
dermal lesion that necroses into an inoculation eschar; the resulting fever, rash
and eschar triad is what makes the group clinically recognisable. The vector genus
and the incubation period are member-specific and are curated on the member
entries.
evidence:
- reference: PMID:15109588
reference_title: Tick-borne rickettsioses in international travellers.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Most patients present with a mild-to-moderately severe flu-like illness typically
accompanied by a cutaneous rash and an inoculation eschar at the site of the tick
bite, but potentially life-threatening disease with disseminated vaculitis is
occasionally seen.
explanation: >-
States the shared presentation of the group in one sentence — the triad plus the
severe vasculitic tail — and locates the eschar at the inoculation site. Evidence
source is OTHER as this is a literature-based review.
- reference: PMID:27172113
reference_title: >-
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain
Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and
Anaplasmosis - United States.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Unlike some SFG rickettsioses, an inoculation eschar is rarely present with RMSF
explanation: >-
Bounds the triad claim: the eschar is characteristic of the group but is
conspicuously absent in its most dangerous member, so its absence cannot be used
to exclude the diagnosis. Evidence source is OTHER as this is a national
recommendations report.
downstream:
- target: Obligate Intracytosolic Infection of Microvascular Endothelium
description: >-
Inoculated organisms disseminate haematogenously and enter endothelial cells,
the group's shared target cell.
causal_link_type: DIRECT
- name: Obligate Intracytosolic Infection of Microvascular Endothelium
biological_scale: CELLULAR
role: effector
description: >-
The mechanistic core shared by every member of the group. SFG rickettsiae adhere
to and induce their own uptake by microvascular endothelial cells, escape the
phagosome into the cytosol, and replicate free in the cytoplasm, exploiting host
actin for both entry and intracellular movement. This node is the group-level
statement of endothelial tropism only; the receptor-ligand detail, the
actin-based motility machinery and the VE-cadherin biology are not re-derived here
and are curated in `Rocky_Mountain_Spotted_Fever.yaml`.
cell_types:
- preferred_term: microvascular endothelial cell
term:
id: CL:2000008
label: microvascular endothelial cell
- preferred_term: blood vessel endothelial cell
term:
id: CL:0000071
label: blood vessel endothelial cell
biological_processes:
- preferred_term: symbiont entry into host
term:
id: GO:0044409
label: symbiont entry into host
modifier: INCREASED
evidence:
- reference: PMID:30148688
reference_title: >-
Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms of an
Endotheliotropic Infection.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Obligately intracytosolic rickettsiae that cycle between arthropod and vertebrate
hosts cause human diseases with a spectrum of severity, primarily by targeting
microvascular endothelial cells, resulting in endothelial dysfunction.
explanation: >-
The definitive statement of the group-level mechanism: intracytosolic lifestyle,
microvascular endothelial target, endothelial dysfunction as the outcome — and
explicitly across a spectrum of severity. Evidence source is OTHER as this is a
review article.
- reference: PMID:30148688
reference_title: >-
Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms of an
Endotheliotropic Infection.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Rickettsiae interact with host cell actin to effect both cellular entry and
intracellular actin-based mobility.
explanation: >-
Supports the entry-and-spread step of this node. Evidence source is OTHER as this
is a review article.
- reference: PMID:26394396
reference_title: >-
Rickettsia massiliae and Rickettsia conorii Israeli Spotted Fever Strain
Differentially Regulate Endothelial Cell Responses.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Rickettsiae primarily target microvascular endothelial cells.
explanation: >-
Independent confirmation of the target cell type from an experimental study
comparing two SFG species in human endothelial monolayers.
downstream:
- target: Species-Graded Endothelial Inflammatory Response
description: >-
Infected endothelium mounts a cytokine, chemokine and adhesion-molecule response
whose magnitude differs sharply between SFG species.
causal_link_type: DIRECT
- target: Disseminated Small-Vessel Vasculitis and Increased Vascular Permeability
description: >-
Multifocal infection of the microvasculature produces a disseminated vasculitis
with barrier failure.
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
- name: Species-Graded Endothelial Inflammatory Response
biological_scale: CELLULAR
role: modifier
description: >-
The node that only a root entry can carry, because it is a statement about the
differences between members rather than about any one of them. Members of the
group share a target cell and a route of infection but differ by orders of
magnitude in severity, from self-limiting African tick-bite fever to frequently
fatal Rocky Mountain spotted fever. That gradient tracks how strongly the
particular species drives interleukin-8 and adhesion-molecule expression in
endothelium and how much endothelial barrier failure and cell death follow: R.
conorii elicits a markedly stronger response in vitro and in patients than R.
africae does, and the Israeli spotted fever strain of R. conorii collapses
endothelial monolayer resistance where the mild pathogen R. massiliae does not.
cell_types:
- preferred_term: microvascular endothelial cell
term:
id: CL:2000008
label: microvascular endothelial cell
biological_processes:
- preferred_term: interleukin-8 production
term:
id: GO:0032637
label: interleukin-8 production
modifier: INCREASED
- preferred_term: leukocyte adhesion to vascular endothelial cell
term:
id: GO:0061756
label: leukocyte adhesion to vascular endothelial cell
modifier: INCREASED
evidence:
- reference: PMID:19091423
reference_title: >-
Relative chemokine and adhesion molecule expression in Mediterranean spotted
fever and African tick bite fever.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Our findings suggest a superior inflammatory potential of R. conorii as compared
to R. africae in endothelial cells, potentially related to the more severe
inflammation in MSF comparing ATBF.
explanation: >-
Directly links a species difference in endothelial inflammatory potential to the
clinical severity difference between two members of the group, using paired in
vitro and patient-serum measurements.
- reference: PMID:19091423
reference_title: >-
Relative chemokine and adhesion molecule expression in Mediterranean spotted
fever and African tick bite fever.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
R. conorii induced a marked increase in MCP-1, IL-8, and adhesion molecules in
endothelial cells, involving toll-like receptor 4 activation.
explanation: >-
Gives the specific mediators behind this node, supporting the IL-8 and
leukocyte-adhesion process annotations.
- reference: PMID:26394396
reference_title: >-
Rickettsia massiliae and Rickettsia conorii Israeli Spotted Fever Strain
Differentially Regulate Endothelial Cell Responses.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Monolayers of endothelial cells infected with R. conorii (ISF) showed a
statistically significant decrease in electrical resistance across the monolayer
compared to both R. massiliae-infected and uninfected cells at 72 HPI, suggesting
increased endothelial permeability.
explanation: >-
A second, independent species pair showing the same pattern — a virulent SFG
species disrupts the endothelial barrier where a mild one does not — measured as
transendothelial electrical resistance.
downstream:
- target: Disseminated Small-Vessel Vasculitis and Increased Vascular Permeability
description: >-
The strength of the endothelial inflammatory and barrier response sets how far
the vasculitic lesion progresses in a given member of the group.
causal_link_type: DIRECT
- name: Disseminated Small-Vessel Vasculitis and Increased Vascular Permeability
biological_scale: TISSUE
role: effector
description: >-
Multifocal endothelial infection and injury produce a disseminated small-vessel
vasculitis with perivascular mononuclear infiltration and loss of endothelial
barrier integrity. This is the single lesion that explains the group's rash, and
at its severe end the oedema of the lungs and brain. The downstream haemostatic
detail — platelet consumption, fibrin thrombi, disseminated intravascular
coagulation — is member-specific and is curated in
`Rocky_Mountain_Spotted_Fever.yaml` rather than repeated here.
cell_types:
- preferred_term: blood vessel endothelial cell
term:
id: CL:0000071
label: blood vessel endothelial cell
biological_processes:
- preferred_term: inflammatory response
term:
id: GO:0006954
label: inflammatory response
modifier: INCREASED
- preferred_term: positive regulation of vascular permeability
term:
id: GO:0043117
label: positive regulation of vascular permeability
modifier: INCREASED
evidence:
- reference: PMID:15109588
reference_title: Tick-borne rickettsioses in international travellers.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Most patients present with a mild-to-moderately severe flu-like illness typically
accompanied by a cutaneous rash and an inoculation eschar at the site of the tick
bite, but potentially life-threatening disease with disseminated vaculitis is
occasionally seen.
explanation: >-
Names disseminated vasculitis as the lesion of severe disease across the group.
Evidence source is OTHER as this is a literature-based review.
- reference: PMID:30148688
reference_title: >-
Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms of an
Endotheliotropic Infection.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Obligately intracytosolic rickettsiae that cycle between arthropod and vertebrate
hosts cause human diseases with a spectrum of severity, primarily by targeting
microvascular endothelial cells, resulting in endothelial dysfunction.
explanation: >-
Endothelial dysfunction is stated as the common outcome of infection across the
group, which is the barrier-failure half of this node. Evidence source is OTHER
as this is a review article.
downstream:
- target: Severe End-Organ Involvement of the Lung and Brain
description: >-
Where permeability failure is extensive, plasma leaks into the pulmonary
interstitium and the brain.
causal_link_type: DIRECT
- name: Severe End-Organ Involvement of the Lung and Brain
biological_scale: ORGANISM
role: consequence
description: >-
The severe tail of the group. Vascular leak in the pulmonary microcirculation
produces non-cardiogenic pulmonary oedema and respiratory failure; in the central
nervous system it produces meningoencephalitis with seizures and coma. These two
are the proximate causes of death across the group, and in a large Brazilian
case-control series seizures and coma were the strongest predictors of a fatal
outcome. Which members reach this node, and how often, differs by species — that
dependency is the point of the `Species-Graded Endothelial Inflammatory Response`
node above.
locations:
- preferred_term: lung
term:
id: UBERON:0002048
label: lung
- preferred_term: brain
term:
id: UBERON:0000955
label: brain
biological_processes:
- preferred_term: positive regulation of vascular permeability
term:
id: GO:0043117
label: positive regulation of vascular permeability
modifier: INCREASED
evidence:
- reference: PMID:28169507
reference_title: Predictive Factors for Fatal Tick-Borne Spotted Fever in Brazil.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
seizures (OR, 11.24; 95% CI, 6.49-19.45) and coma (OR of 15.16; 95% CI,
8.51-27.02)
explanation: >-
Quantifies the neurological arm of this node as the strongest predictor of death
in a 386-case, 415-control series of tick-borne spotted fever.
- reference: PMID:15109588
reference_title: Tick-borne rickettsioses in international travellers.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Most patients present with a mild-to-moderately severe flu-like illness typically
accompanied by a cutaneous rash and an inoculation eschar at the site of the tick
bite, but potentially life-threatening disease with disseminated vaculitis is
occasionally seen.
explanation: >-
Establishes that a life-threatening vasculitic course occurs across the group but
is the exception rather than the rule. Recorded as PARTIAL because it does not
name the specific pulmonary and neurological end-organs. Evidence source is OTHER
as this is a literature-based review.
notes: >-
Non-cardiogenic pulmonary oedema is named in the description because it is the
standard characterisation of the severe pulmonary lesion in this group, but no
cited abstract in this entry states it in those words, so no evidence item claims
it. The evidenced content of this node is the neurological arm plus the
group-level statement that a life-threatening vasculitic course occurs. The
pulmonary arm is curated with its own evidence on
`Rocky_Mountain_Spotted_Fever.yaml`.
- name: Rickettsial Ribosomal Translation (Doxycycline Target)
biological_scale: MOLECULAR
role: therapeutic_vulnerability
conforms_to: "bacterial_protein_synthesis_inhibition#Bacterial mRNA Translation by the Ribosome"
description: >-
Every member of the group depends on its own 70S ribosome for protein synthesis,
and that ribosome — not a cell-wall target — is what doxycycline inhibits. The
molecular mechanism is held once in the
`bacterial_protein_synthesis_inhibition` module and is not re-derived here; this
node exists so the group-level doxycycline recommendation has a mechanism node to
point at.
biological_processes:
- preferred_term: translation
term:
id: GO:0006412
label: translation
evidence:
- reference: PMID:24336183
reference_title: Ribosome-targeting antibiotics and mechanisms of bacterial resistance.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The ribosome is one of the main antibiotic targets in the bacterial cell.
explanation: >-
Establishes the bacterial ribosome as the target of the tetracyclines and the
other protein-synthesis inhibitors — the molecular step this node represents. The
same reference anchors the equivalent node in `Rocky_Mountain_Spotted_Fever.yaml`
and `Murine_Typhus.yaml`. Evidence source is OTHER as this is a review article.
- reference: PMID:15109588
reference_title: Tick-borne rickettsioses in international travellers.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Doxycycline is the recommended treatment for tick-borne rickettsioses and
prevention is based on personal protective measures against tick bites when
travelling in endemic areas.
explanation: >-
Establishes at group level that a tetracycline — a ribosome-targeting agent — is
the recommended therapy, which is the clinical fact this target node underwrites.
Evidence source is OTHER as this is a literature-based review.
- name: Obligate Intracytosolic Niche (Cell-Penetrant Drug Requirement)
biological_scale: CELLULAR
role: intrinsic_resistance
conforms_to: "intracellular_pathogen_persistence#Requirement for Cell-Penetrant Antimicrobials"
description: >-
Because SFG rickettsiae replicate free in the host cell cytosol, effective therapy
is restricted to agents that accumulate intracellularly. Doxycycline does;
beta-lactams do not reach the organism whatever their in vitro activity. This is
the pharmacokinetic gate that, together with the ribosomal target above, makes
doxycycline first-line for every member of the group regardless of species or
geography. The gating principle itself is held once in the
`intracellular_pathogen_persistence` module.
biological_processes:
- preferred_term: response to antibiotic
term:
id: GO:0046677
label: response to antibiotic
evidence:
- reference: PMID:30148688
reference_title: >-
Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms of an
Endotheliotropic Infection.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Obligately intracytosolic rickettsiae that cycle between arthropod and vertebrate
hosts cause human diseases with a spectrum of severity, primarily by targeting
microvascular endothelial cells, resulting in endothelial dysfunction.
explanation: >-
Establishes the obligately intracytosolic lifestyle that creates the penetration
constraint this node represents. Evidence source is OTHER as this is a review
article.
- reference: PMID:18611821
reference_title: Intracellular organisms.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The intracellular location of some microorganisms allow them to resist antibiotics
with poor ability to penetrate eukaryotic cell membranes, such as the beta-lactam
compounds.
explanation: >-
The exclusion half of the gating principle: the intracellular niche confers
resistance to poorly cell-penetrant agents such as the beta-lactams. This is the
same anchor the `intracellular_pathogen_persistence` module uses. Evidence source
is OTHER as this is a review article.
- reference: PMID:28639230
reference_title: >-
Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Therapeutic efficacy against intracellular pathogens has been correlated mainly
with the intracellular concentrations achieved by the different antimicrobial
agents.
explanation: >-
The requirement half of the gating principle, and the evidence the module node
this entry conforms to is itself built on: efficacy tracks the intracellular
concentration achieved, not the in vitro MIC. Evidence source is OTHER as this is
a review article.
- reference: PMID:27172113
reference_title: >-
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain
Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and
Anaplasmosis - United States.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Doxycycline is the drug of choice for treatment of all tickborne rickettsial
diseases in patients of all ages, including children aged <8 years
explanation: >-
The clinical corollary of the penetration constraint: one cell-penetrant agent is
recommended across the whole group. Evidence source is OTHER as this is a
national recommendations report.
phenotypes:
- category: Infectious
name: Fever
description: >-
Fever is present in essentially every member of the group and is the presenting
complaint. Per-member frequency figures are curated on the member entries.
phenotype_term:
preferred_term: Fever
term:
id: HP:0001945
label: Fever
evidence:
- reference: PMID:12766836
reference_title: African tick bite fever in travelers to rural sub-Equatorial Africa.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
More than 80% of the patients had fever, headache, and/or myalgia, whereas
specific clinical features such as inoculation eschars, lymphadenitis, cutaneous
rash, and aphthous stomatitis were seen in < or = 50% of patients.
explanation: >-
Establishes that fever belongs to the dominant early symptom complex, but supports
the phenotype only PARTIALLY and supports no frequency band. The reported ">80%"
is a disjunction — it counts patients with fever, headache and/or myalgia, so it
cannot be distributed across its three disjuncts to give a rate for fever alone.
The denominator is also a single member (n=38 African tick-bite fever patients,
the mildest member of the group) rather than the group. `frequency` is therefore
omitted, on the same grounds as for rash and eschar below, which are bounded by
the second half of this same sentence.
- category: Dermatological
name: Skin rash
description: >-
A cutaneous eruption — usually maculopapular, sometimes petechial or (in
rickettsialpox) papulovesicular — is the feature that gives the group its name. Its
distribution, timing and morphology are member-specific.
phenotype_term:
preferred_term: Skin rash
term:
id: HP:0000988
label: Skin rash
evidence:
- reference: PMID:15109588
reference_title: Tick-borne rickettsioses in international travellers.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Most patients present with a mild-to-moderately severe flu-like illness typically
accompanied by a cutaneous rash and an inoculation eschar at the site of the tick
bite, but potentially life-threatening disease with disseminated vaculitis is
occasionally seen.
explanation: >-
States the rash as a typical accompaniment across the group. `frequency` is
deliberately omitted: "typically accompanied by" does not license a band, and the
one quantitative cohort cited here reports rash in half or fewer of ATBF patients,
so no single band holds across the group. Evidence source is OTHER as this is a
literature-based review.
- category: Dermatological
name: Inoculation eschar
description: >-
A necrotic, dark-scabbed lesion at the arthropod attachment site (the tache noire
of Mediterranean spotted fever), which in most members of the group precedes the
fever. It is a group-level diagnostic asset with a group-level trap attached: it is
characteristically ABSENT in Rocky Mountain spotted fever, the member in which
missing the diagnosis is most dangerous.
phenotype_term:
preferred_term: Eschar
term:
id: HP:6000793
label: Eschar
diagnostic: true
evidence:
- reference: PMID:15109588
reference_title: Tick-borne rickettsioses in international travellers.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Most patients present with a mild-to-moderately severe flu-like illness typically
accompanied by a cutaneous rash and an inoculation eschar at the site of the tick
bite, but potentially life-threatening disease with disseminated vaculitis is
occasionally seen.
explanation: >-
States the inoculation eschar as a typical group-level feature and locates it at
the bite site. Evidence source is OTHER as this is a literature-based review.
- reference: PMID:27172113
reference_title: >-
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain
Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and
Anaplasmosis - United States.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Unlike some SFG rickettsioses, an inoculation eschar is rarely present with RMSF
explanation: >-
Recorded as PARTIAL because it supports the phenotype's presence in the group only
by contrast, while refuting its presence in one member. That is exactly the bound
the description records, and it is why `frequency` is omitted. Evidence source is
OTHER as this is a national recommendations report.
- category: Neurological
name: Headache
description: Headache is part of the near-universal early triad with fever and myalgia.
phenotype_term:
preferred_term: Headache
term:
id: HP:0002315
label: Headache
evidence:
- reference: PMID:12766836
reference_title: African tick bite fever in travelers to rural sub-Equatorial Africa.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
More than 80% of the patients had fever, headache, and/or myalgia, whereas
specific clinical features such as inoculation eschars, lymphadenitis, cutaneous
rash, and aphthous stomatitis were seen in < or = 50% of patients.
explanation: >-
Places headache in the dominant early symptom complex. Recorded as PARTIAL and
with no frequency band: the cohort reports the three symptoms as an "and/or"
disjunction, so the ">80%" figure applies to the complex as a whole and cannot be
read as a rate for headache.
- category: Constitutional
name: Myalgia
description: Myalgia completes the nonspecific early triad.
phenotype_term:
preferred_term: Myalgia
term:
id: HP:0003326
label: Myalgia
evidence:
- reference: PMID:12766836
reference_title: African tick bite fever in travelers to rural sub-Equatorial Africa.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
More than 80% of the patients had fever, headache, and/or myalgia, whereas
specific clinical features such as inoculation eschars, lymphadenitis, cutaneous
rash, and aphthous stomatitis were seen in < or = 50% of patients.
explanation: >-
Places myalgia in the dominant early symptom complex. Recorded as PARTIAL and with
no frequency band, for the same reason as fever and headache above — the ">80%"
figure is reported over an "and/or" disjunction of the three symptoms and is not
divisible among them.
diagnosis:
- name: Empiric clinical and epidemiologic diagnosis
description: >-
Across the whole group, the diagnosis is made clinically and epidemiologically and
treatment is started on suspicion. Confirmatory testing is retrospective in
practice, an absent tick-bite history is common and does not argue against the
diagnosis, and waiting for a laboratory result costs lives.
diagnosis_term:
preferred_term: clinical evaluation
term:
id: NCIT:C124351
label: Clinical Evaluation
evidence:
- reference: PMID:15109588
reference_title: Tick-borne rickettsioses in international travellers.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Definite microbiological confirmation of tick-borne rickettsioses by isolation or
antigen detection is only available at reference laboratories and diagnosis must
in most cases rely on clinical and epidemiological data supported by serology.
explanation: >-
States the group-level diagnostic reality: clinical and epidemiological
assessment, with serology as support rather than as the primary test. Evidence
source is OTHER as this is a literature-based review.
- reference: PMID:15109588
reference_title: Tick-borne rickettsioses in international travellers.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Only a minority of infected travellers can recall a preceding tick bite.
explanation: >-
Supports the specific caution that an absent exposure history does not exclude the
diagnosis. Evidence source is OTHER as this is a literature-based review.
notes: >-
`diagnosis_term` is bound to `NCIT:C124351` (Clinical Evaluation) rather than the
broader laboratory-procedure term used for the same node in
`Rocky_Mountain_Spotted_Fever.yaml`. The divergence is deliberate: this node's claim
is that treatment starts on clinical and epidemiologic grounds *without* laboratory
confirmation, so a laboratory-procedure term would contradict the claim it annotates.
The specific confirmatory modalities (paired-serum IFA, whole-blood PCR, eschar-swab
PCR, immunohistochemistry on skin biopsy) are curated with their own terms on the
member entries.
- name: Group-specific serology and the species-level limit
description: >-
Serology is the mainstay of confirmation for the whole group, and it is
group-specific rather than species-specific. The immunodominant response is against
spotted fever group lipopolysaccharide, which is shared, rather than against the
OmpA and OmpB outer-membrane proteins that carry the species-specific epitopes. A
reactive R. rickettsii titre therefore establishes infection with an SFG rickettsia,
not with R. rickettsii — which is why species assignment needs cross-adsorption,
Western blot, PCR or culture, and why the individual member diseases are so often
reported as an undifferentiated "spotted fever group rickettsiosis". This is a claim
about the group as a whole and has no home on any member entry.
diagnosis_term:
preferred_term: serologic testing
term:
id: NCIT:C25294
label: Laboratory Procedure
evidence:
- reference: PMID:27172113
reference_title: >-
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain
Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and
Anaplasmosis - United States.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Cross-reactive immune responses to rickettsial antigens result in antibodies that
are typically group-specific, although perhaps not species-specific, for tickborne
rickettsial pathogens
explanation: >-
The direct statement of the group-versus-species resolution limit of rickettsial
serology. Evidence source is OTHER as this is a national recommendations report.
- reference: PMID:27172113
reference_title: >-
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain
Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and
Anaplasmosis - United States.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
antibodies reactive with R. rickettsii detected by a serologic test could result
from infection with other SFG rickettsiae
explanation: >-
The worked consequence: a positive R. rickettsii serology does not identify the
species. Evidence source is OTHER as this is a national recommendations report.
- reference: PMID:10497980
reference_title: >-
Serologic study of the prevalence of rickettsiosis in Yucatán: evidence for a
prevalent spotted fever group rickettsiosis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Immunoblotting with antigens of R. akari identified antibodies against antigens of
spotted fever group lipopolysaccharides and not against rickettsial outer membrane
proteins A and B, which contain the species-specific epitopes.
explanation: >-
Gives the molecular reason for the cross-reactivity: the dominant response is
against shared group lipopolysaccharide rather than the species-specific OmpA and
OmpB epitopes.
treatments:
- name: Empiric doxycycline for all patients of all ages
action_category: THERAPEUTIC
description: >-
One recommendation covers the entire group: doxycycline, started immediately on
clinical suspicion, in patients of every age including children under eight. This
is a genuinely group-level rule — it does not depend on which SFG species is
involved, and it is made before the species (or often even the group) is known,
which is what makes it a root-level claim rather than a per-member one. Its two
mechanistic legs are the shared rickettsial ribosome and the shared cytosolic
niche, both modelled above. The historical reluctance to give doxycycline to young
children has been overturned: the concern derived from older tetracyclines that
bind calcium more readily, and a CDC cohort of 58 children given short courses
before age eight showed no dental staining, no enamel hypoplasia and no difference
in tooth shade against 213 unexposed controls. Per-member specifics — the day-5
mortality window in RMSF, the sulfonamide contraindication, macrolide alternatives
in pregnancy — are curated on the member entries.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: doxycycline
term:
id: CHEBI:50845
label: doxycycline
target_mechanisms:
- target: Rickettsial Ribosomal Translation (Doxycycline Target)
treatment_effect: INHIBITS
description: >-
Doxycycline binds the bacterial 30S ribosomal subunit and arrests rickettsial
protein synthesis. The molecular detail is held in the
`bacterial_protein_synthesis_inhibition` module.
evidence:
- reference: PMID:15109588
reference_title: Tick-borne rickettsioses in international travellers.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Doxycycline is the recommended treatment for tick-borne rickettsioses and
prevention is based on personal protective measures against tick bites when
travelling in endemic areas.
explanation: >-
Establishes that the recommended agent for the group is a tetracycline, that is,
a ribosome-targeting drug acting on this node. Evidence source is OTHER as this
is a literature-based review.
- target: Obligate Intracytosolic Niche (Cell-Penetrant Drug Requirement)
treatment_effect: BYPASSES
description: >-
Doxycycline accumulates within host cells and so reaches the cytosolic organism
that poorly penetrant agents such as the beta-lactams cannot.
evidence:
- reference: PMID:27172113
reference_title: >-
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain
Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and
Anaplasmosis - United States.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Doxycycline is the drug of choice for treatment of all tickborne rickettsial
diseases in patients of all ages, including children aged <8 years
explanation: >-
A single cell-penetrant agent is recommended across the whole group, which is
the clinical expression of this pharmacokinetic gate. Evidence source is OTHER
as this is a national recommendations report.
evidence:
- reference: PMID:27172113
reference_title: >-
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain
Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and
Anaplasmosis - United States.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Doxycycline is the drug of choice for treatment of all tickborne rickettsial
diseases in patients of all ages, including children aged <8 years
explanation: >-
The group-level recommendation in the CDC's own words, covering all members and
all ages. Evidence source is OTHER as this is a national recommendations report.
- reference: PMID:27172113
reference_title: >-
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain
Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and
Anaplasmosis - United States.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
The American Academy of Pediatrics and CDC recommend doxycycline as the treatment
of choice for children of all ages with suspected tickborne rickettsial disease
explanation: >-
The paediatric arm of the recommendation, endorsed jointly by AAP and CDC.
Evidence source is OTHER as this is a national recommendations report.
- reference: PMID:27172113
reference_title: >-
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain
Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and
Anaplasmosis - United States.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Previous concerns about tooth staining in children aged <8 years stem from
experience with older tetracycline-class drugs that bind more readily to calcium
than newer members of the drug class, such as doxycycline
explanation: >-
Explains why the old paediatric contraindication was wrong for doxycycline
specifically — it was inherited from drugs with different calcium binding.
Evidence source is OTHER as this is a national recommendations report.
- reference: PMID:25794784
reference_title: >-
No visible dental staining in children treated with doxycycline for suspected
Rocky Mountain Spotted Fever.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
No tetracycline-like staining was observed in any of the exposed children's teeth
(0/58, 95% CI 0%-5%), and no significant difference in tooth shade (P=.20) or
hypoplasia (P=1.0) was found between the 2 groups.
explanation: >-
The primary cohort study that removed the age barrier: no staining, no hypoplasia
and no shade difference in 58 exposed versus 213 unexposed children.
- reference: PMID:15109588
reference_title: Tick-borne rickettsioses in international travellers.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Doxycycline is the recommended treatment for tick-borne rickettsioses and
prevention is based on personal protective measures against tick bites when
travelling in endemic areas.
explanation: >-
Independent confirmation from the travel-medicine literature that the same agent
is recommended for the group outside the United States, that is, that the rule is
not a CDC-local one. Evidence source is OTHER as this is a literature-based
review.
discussions:
- discussion_id: sfr_root_disease_vs_grouping
kind: INTERPRETATION
status: RESOLVED
prompt: >-
Should spotted fever (MONDO:0001195) be modelled as a root `Disease` with
`has_subtypes`, or as a `Grouping` over the member entries in `kb/groupings/`?
rationale: >-
Resolved in favour of a root `Disease` with `has_subtypes`, on three grounds, the
second of which is decisive on its own. First, tooling: `build_coverage_index()` in
`src/dismech/compare/mondo_priority.py` calls `iter_disease_files()`, which globs
`*.yaml` under the `--kb-dir` default of `kb/disorders` and never reads
`kb/groupings/`. A `Grouping` alone would leave MONDO:0001195 permanently on the
MONDO curation queue no matter how well curated it was. This was verified by reading
`mondo_priority.py`, `compare/support.py` and the `--kb-dir` default in
`priority_dashboard.py`, not assumed from the thanatophoric-dysplasia precedent.
Second, and specific to this case:
`tests/test_data.py::test_grouping_member_foreign_keys` requires every
`members[].member` of a Grouping to resolve to a real `Disease.name`, module stem or
grouping name. Only two of the six members curated here — Rocky Mountain spotted
fever and boutonneuse fever — have standalone `kb/disorders/` entries; African
tick-bite fever, rickettsialpox, Queensland tick typhus and North Asian tick typhus
do not. A Grouping could therefore not list four of its six members at all, whereas
`has_subtypes` carries them with their MONDO bindings and their evidence today and
loses nothing when they are later promoted to standalone entries. Third, substance:
several claims here are defined over the union and have no home on any member — the
SFG taxon itself (NCBITaxon:114277), the group-versus-species resolution limit of
rickettsial serology (PMID:27172113, PMID:10497980), the species-graded severity
gradient (PMID:19091423, PMID:26394396), and the single all-ages doxycycline rule
that is applied before the species is known (PMID:27172113). Note this differs from
the thanatophoric-dysplasia case in one respect worth recording: there, a
pre-existing grouping (`FGFR_Related_Skeletal_Dysplasias`) already unioned the
members, so a second grouping would have been redundant. Here there is no rickettsial
grouping at all, so the redundancy argument does not apply — the case rests on the
coverage-index and foreign-key arguments instead. The counter-argument, that a
Disease root duplicates content already held in the two curated member entries, is
addressed by keeping this root deliberately thin: seven pathophysiology nodes, two of
which are module `conforms_to` anchors, and explicit "not re-derived here" pointers
on the nodes that the member entries carry in depth.
resolution_note: >-
Curated as a root `Disease` (this entry). No grouping was created. If African
tick-bite fever, rickettsialpox, Queensland tick typhus and North Asian tick typhus
are later curated as standalone entries, a `Grouping` over the six becomes viable
and could be added alongside this root — it would then carry the auditable
membership criteria that `has_subtypes` cannot express — but it would still not
retire MONDO:0001195 from the priority queue, so this entry would remain.
posed_by: dismech curation (issue #8890)
posed_date: '2026-08-19T00:00:00Z'
resolved_date: '2026-08-19T00:00:00Z'
- discussion_id: sfr_subtype_axis_species_not_geography
kind: INTERPRETATION
status: RESOLVED
prompt: >-
Should the subtypes of this group be organised by causative Rickettsia species or by
geography? The two largely co-vary, and MONDO's own children mix both conventions
(Japanese spotted fever and African tick-bite fever are geographic labels;
Rickettsia parkeri spotted fever is a species label).
attaches_to:
- pathophysiology#Species-Graded Endothelial Inflammatory Response
rationale: >-
Resolved in favour of the species. Geography is a downstream label set by the range
of the vector tick, and it fails as an identity criterion in both directions. It is
not one-to-one downward: a single species, R. conorii, carries four distinct
geographically named diseases — Mediterranean spotted fever, Indian tick typhus,
Israeli spotted fever and Astrakhan fever — which are genotypically homogeneous but
serotypically and epidemio-clinically distinct (PMID:15766388). And it is not
one-to-one upward: a single species, R. rickettsii, causes Rocky Mountain spotted
fever in North America and Brazilian spotted fever in South America (PMID:28169507),
so the geographic name changes while the organism does not. The species axis also
tracks the thing that actually matters clinically. Severity across this group spans
from self-limiting to frequently fatal, and that gradient follows the
species-specific endothelial inflammatory response (PMID:19091423, PMID:26394396)
rather than the latitude at which the tick bit. Geography is retained, but as the
secondary descriptor it is: each `has_subtypes` entry carries a `geography` list
alongside its species-named `display_name`.
resolution_note: >-
Subtypes are keyed on the causative species, with `geography` recorded per subtype.
The list is explicitly non-exhaustive — MONDO:0001195 has seventeen descendants and
new SFG species of undetermined pathogenicity continue to be described
(PMID:24092850). The six curated here were chosen to span the severity range (RMSF
to ATBF), both continents on which one species operates, both vector classes (tick
and mite), and both naming traps ("tick typhus" that is SFG). Japanese spotted
fever, Flinders Island spotted fever, Astrakhan spotted fever, Israeli tick typhus,
Indian tick typhus, Far Eastern spotted fever, R. parkeri spotted fever and R.
helvetica spotted fever all have MONDO terms and are candidates for a later tranche.
posed_by: dismech curation (issue #8890)
posed_date: '2026-08-19T00:00:00Z'
resolved_date: '2026-08-19T00:00:00Z'
- discussion_id: sfr_group_boundary_and_naming_traps
kind: OPEN_QUESTION
status: OPEN
prompt: >-
What exactly is the unifying criterion for membership of this group, given that the
disease grouping, the arthropod vector and the current rickettsial phylogeny do not
coincide?
rationale: >-
Three boundary problems sit under this entry, and they are recorded rather than
resolved because resolving them is an ontology question, not a curation one.
First, the vector is not the criterion. MONDO defines MONDO:0001195 as "a type of
tick-borne disease", yet places rickettsialpox (MONDO:0019360) under it, and
rickettsialpox is mite-borne (PMID:28846279). Either the definition is too narrow or
rickettsialpox is misplaced. This entry takes the first reading and treats the
rickettsial clade, not the arthropod, as the unifying criterion — which is the
reading that matches how the diseases are diagnosed, since rickettsialpox eschars
stain positive for spotted fever group rickettsiae (PMID:12860597).
Second, the clade itself has moved. Gillespie et al. proposed a fourth rickettsial
lineage, the transitional group, distinct from both the spotted fever and typhus
groups (PMID:17342200), and both R. akari and R. australis have since been assigned
to it (PMID:28846279). Two of the six members curated here are therefore, on current
genomic classification, not spotted fever group organisms — while remaining spotted
fever group DISEASES clinically, serologically and therapeutically. This entry keeps
them, on the grounds that a dismech disease entry groups diseases by shared
pathophysiology and management rather than by the current state of bacterial
systematics, but a reviewer should know the tension exists and that MONDO has not
tracked the reclassification.
Third, the names lie in both directions. Queensland tick typhus and North Asian
(Siberian) tick typhus are spotted fever group diseases despite the word "typhus"
(PMID:28719297, PMID:22493192), whereas murine typhus and epidemic typhus are typhus
group and scrub typhus is not even a Rickettsia (Orientia tsutsugamushi). This is a
live Named Entity Confusion hazard for anyone curating from a deep-research report:
a search on "tick typhus" will return both groups. `kb/disorders/Murine_Typhus.yaml`
is deliberately NOT a member of this group and must not be added to it.
posed_by: dismech curation (issue #8890)
posed_date: '2026-08-19T00:00:00Z'
- discussion_id: sfr_root_severity_gradient_mechanism
kind: KNOWLEDGE_GAP
status: OPEN
prompt: >-
What determines the severity gradient across spotted fever group species — from
self-limiting African tick-bite fever to frequently fatal Rocky Mountain spotted
fever — given that all members share the same endothelial target cell and the same
intracytosolic lifestyle?
attaches_to:
- pathophysiology#Species-Graded Endothelial Inflammatory Response
rationale: >-
The evidence curated here establishes that the gradient exists and correlates with
the strength of the endothelial inflammatory and barrier response the species
provokes (PMID:19091423, PMID:26394396). It does not establish what makes one
species provoke that response more strongly than another. The two studies cited
compare only two species pairs (R. conorii versus R. africae; R. conorii ISF versus
R. massiliae), both use immortalised or primary human endothelial monolayers rather
than intact microvasculature, and neither identifies the bacterial determinant
responsible. Host factors known to worsen individual members — G6PD deficiency in
RMSF, age and comorbidity in MSF — are curated on the member entries and are a
separate axis from the species difference modelled here.
proposed_experiments:
- experiment_id: exp_sfr_multispecies_endothelial_panel
name: Matched multi-species endothelial infection panel across the severity range
description: >-
Infect a single human microvascular endothelial preparation with a panel of SFG
species spanning the clinical severity range (R. rickettsii, R. conorii subsp.
conorii, R. africae, R. akari, R. australis, R. parkeri) at matched multiplicity,
and measure a common readout set — transendothelial electrical resistance, IL-8
and adhesion-molecule induction, and cell death — so that severity rank can be
regressed against endothelial response rather than inferred from separate
pairwise studies. Pair with comparative genomics across the same panel to nominate
the bacterial determinants.
posed_by: dismech curation (issue #8890)
posed_date: '2026-08-19T00:00:00Z'
notes: >
Scope. This entry is deliberately thin, in the sense used by
`kb/disorders/Thanatophoric_Dysplasia.yaml`. It carries only claims that are defined
over the spotted fever group as a whole and that therefore have no home on any single
member: the SFG taxon and the species-versus-geography naming problem, the shared
eschar, fever and rash triad together with the RMSF exception that bounds it, the
group-versus-species resolution limit of rickettsial serology, the single all-ages
doxycycline rule and its paediatric arm, and the SFG-versus-typhus-group boundary.
The endothelial pathophysiology is stated once, at group level, with explicit
pointers to where it is curated in depth; the VE-cadherin and coagulation arms, the
cytotoxic T cell clearance arm, the per-member epidemiology, phenotype frequencies,
differential diagnoses, histopathology and second-line therapy are NOT re-derived
here. `Rocky_Mountain_Spotted_Fever.yaml` (2,119 lines) and `Boutonneuse_Fever.yaml`
(1,273 lines) carry those. `Murine_Typhus.yaml` is typhus group, not spotted fever
group, and is deliberately out of scope; it is a useful contrast and shares the two
antimicrobial modules, but it is not a member of this group.
Deep research. No new deep-research provider pass was run for this entry, by
instruction. `research/Rocky_Mountain_Spotted_Fever-deep-research-claude_code.md` and
`research/Boutonneuse_Fever-deep-research-fallback.md` were available as leads for the
two curated members; every claim here was built from primary literature fetched
directly from PubMed and verified against `references_cache/`. Because no
deep-research report drives any claim, `just preflight-dr` is not applicable. Named
Entity Confusion discipline was applied manually and mattered more than usual for this
family: every cited abstract was checked to confirm which Rickettsia species it
concerns, no paper about rickettsiosis in general is cited for an SFG-specific claim,
and the "tick typhus" versus "typhus group" versus "scrub typhus" trap is recorded
explicitly in the `sfr_group_boundary_and_naming_traps` discussion rather than left
implicit.
Sources not usable at curation time. Orphanet ORPHA:102022, which MONDO:0001195 xrefs
and which would supply a quotable group-level definition and an epidemiology table,
could not be cached: `just refresh-orphadata` fails a sha256 check against the pinned
`data/orphadata/MANIFEST.yaml` because upstream Orphadata has drifted, and re-pinning
the manifest would rebuild every `references_cache/ORPHA_*.md` in the repository. Both
curated member entries already cite their own ORPHA records from the existing cache.
No prevalence block is curated here as a result: population occurrence for this group
is reported per member and per country, not for the union, and inventing a
group-level figure from the member figures would be a fabricated aggregate.
references:
- reference: PMID:24092850
title: "Update on tick-borne rickettsioses around the world: a geographic approach."
findings:
- statement: >-
Defines tick-borne rickettsioses as caused by obligate intracellular bacteria of
the spotted fever group of the genus Rickettsia
- statement: >-
Records that the group's membership is open — species once thought nonpathogenic
are now recognised as human pathogens and novel species continue to be found
- reference: PMID:27172113
title: >-
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted
Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis -
United States.
findings:
- statement: >-
Doxycycline is the drug of choice for all tickborne rickettsial diseases in
patients of all ages, including children under 8
- statement: >-
Rickettsial serology is group-specific but not species-specific; a reactive R.
rickettsii titre can result from any SFG infection
- statement: >-
An inoculation eschar is rarely present in RMSF, unlike some other SFG
rickettsioses
- reference: PMID:25794784
title: >-
No visible dental staining in children treated with doxycycline for suspected Rocky
Mountain Spotted Fever.
findings:
- statement: >-
No dental staining, enamel hypoplasia or tooth-shade difference in 58 children
given short doxycycline courses before age 8 versus 213 unexposed controls
- reference: PMID:15109588
title: Tick-borne rickettsioses in international travellers.
findings:
- statement: >-
States the group-level presentation: flu-like illness with cutaneous rash and
inoculation eschar, occasionally life-threatening disseminated vasculitis
- statement: Only a minority of infected travellers recall a preceding tick bite
- statement: Doxycycline is the recommended treatment for tick-borne rickettsioses
- reference: PMID:30148688
title: >-
Pathogenesis of Rickettsial Diseases: Pathogenic and Immune Mechanisms of an
Endotheliotropic Infection.
findings:
- statement: >-
Obligately intracytosolic rickettsiae target microvascular endothelial cells,
producing endothelial dysfunction across a spectrum of disease severity
- reference: PMID:10497980
title: >-
Serologic study of the prevalence of rickettsiosis in Yucatán: evidence for a
prevalent spotted fever group rickettsiosis.
findings:
- statement: >-
The dominant antibody response is against shared SFG lipopolysaccharide rather
than the OmpA and OmpB proteins carrying species-specific epitopes
- reference: PMID:17342200
title: "Plasmids and rickettsial evolution: insight from Rickettsia felis."
findings:
- statement: >-
Proposes the transitional group as a fourth rickettsial lineage distinct from the
spotted fever and typhus groups
- reference: PMID:15766388
title: >-
Proposal to create subspecies of Rickettsia conorii based on multi-locus sequence
typing and an emended description of Rickettsia conorii.
findings:
- statement: >-
One genotypically homogeneous species, R. conorii, underlies four
epidemio-clinically distinct geographically named diseases
- reference: PMID:26394396
title: >-
Rickettsia massiliae and Rickettsia conorii Israeli Spotted Fever Strain
Differentially Regulate Endothelial Cell Responses.
findings:
- statement: >-
A virulent SFG strain reduces endothelial monolayer electrical resistance while a
mild one does not, at matched infection
- reference: PMID:19091423
title: >-
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever
and African tick bite fever.
findings:
- statement: >-
R. conorii has a superior endothelial inflammatory potential to R. africae,
matching the severity difference between MSF and ATBF
- reference: PMID:28169507
title: Predictive Factors for Fatal Tick-Borne Spotted Fever in Brazil.
findings:
- statement: Seizures and coma are the strongest predictors of fatal spotted fever
- statement: >-
R. rickettsii causes tick-borne spotted fever in Brazil as well as North America
- reference: PMID:12766836
title: African tick bite fever in travelers to rural sub-Equatorial Africa.
findings:
- statement: >-
Over 80% of ATBF patients had fever, headache and/or myalgia; eschar, rash and
lymphadenitis were present in half or fewer
- reference: PMID:12860597
title: "Rickettsialpox in New York City: a persistent urban zoonosis."
findings:
- statement: >-
Rickettsialpox eschars and papular lesions stain positive for spotted fever group
rickettsiae
- reference: PMID:28846279
title: Rickettsia akari (Rickettsialpox).
findings:
- statement: R. akari is transmitted by the house mouse mite, not a tick
- statement: >-
R. akari was initially classified in the spotted fever group but is now placed in
the transitional group
- reference: PMID:28719297
title: >-
Rickettsia australis and Queensland Tick Typhus: A Rickettsial Spotted Fever Group
Infection in Australia.
findings:
- statement: >-
Queensland tick typhus, despite its name, is a spotted fever group infection
caused by R. australis
- reference: PMID:22493192
title: Sequence and annotation of Rickettsia sibirica sibirica genome.
findings:
- statement: >-
R. sibirica subsp. sibirica is the agent of Siberian / North Asian tick typhus in
Siberia and eastern China
- reference: PMID:17961858
title: Rocky Mountain spotted fever.
findings:
- statement: >-
RMSF is a life-threatening disease caused by the obligately intracellular R.
rickettsii, spread by ticks
- reference: PMID:23168048
title: Mediterranean spotted fever in the Trakya region of Turkey.
findings:
- statement: >-
MSF is caused by R. conorii subsp. conorii, a member of the spotted fever group
- reference: PMID:24336183
title: Ribosome-targeting antibiotics and mechanisms of bacterial resistance.
findings:
- statement: >-
The bacterial ribosome is one of the main antibiotic targets, the molecular target
of the tetracyclines used across this group
- reference: PMID:18611821
title: Intracellular organisms.
findings:
- statement: >-
The intracellular niche confers resistance to poorly cell-penetrant antibiotics
such as the beta-lactams
- reference: PMID:28639230
title: Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications.
findings:
- statement: >-
Efficacy against intracellular pathogens tracks the intracellular concentration
achieved rather than the in vitro MIC
clinical_trials: []
datasets: []